This article is brought to you in association with the European Commission. Today, the European Medicines Agency (EMA) has given a positive opinion on two COVID-19 treatments – Ronapreve and Regkirona – identified by the Commission as promising therapeutics under the EU Strategy on COVID-19 Therapeutics. Both are treatments for use during the early stages of […]European Health Union: green light for two new COVID-19 therapeutics
November 12, 2021 by 1 Comment
This article is brought to you in association with the European Commission. Today, the European Medicines Agency (EMA) has given a positive opinion on two COVID-19 treatments – Ronapreve and Regkirona – identified by the Commission as promising therapeutics under the EU Strategy on COVID-19 Therapeutics. Both are treatments for use during the early stages of […]COVID-19 Therapeutics Strategy: Commission identifies five promising candidate therapeutics
June 29, 2021 by Leave a Comment
This article is brought to you in association with the European Commission. The EU Strategy on COVID-19 Therapeutics delivers today its first outcome, with the announcement of the first portfolio of five therapeutics that could soon be available to treat patients across the EU. Four of these therapeutics are monoclonal antibodies under rolling review by the […]Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics
May 7, 2021 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Today’s Strategy covers the full lifecycle of medicines: from research, […]
